Welcome to Nordic Society of Gynaecological Oncology

ENGOT-ov24-NSGO/AVANOVA

  

Study documentation (link to documents, only accessible with password to www.nsgo.org). Click  HERE for access.  

 

Study sponsor

NSGO

NSGO Project Manager

Louisa Boufercha
NSGO, Rigshospitalet, Copenhagen, Denmark

louisa.boufercha@regionh.dk

+45 3545 3398

Study chair

Mansoor Raza Mirza
NSGO, Rigshospitalet Copenhagen, Denmark

mansoor.raza.mirza@regionh.dk

+45 3545 9624

Drug

Niraparib and Bevacizumab

Phase

II

Randomized trial

Yes

Type

Open-label

Total number of patients

94 patients required 

Number of patients recruited

Recruitment statistics – link

Trial status

Recruitment closed

Date of first site activated

02.03.2016

eCRF

Open Clinica test – link (protected information – access only with login)

Open Clinica Live – link (protected information – access only with login)

Site list

Site list – link (protected information – access only with login)

Protocol summary

ClinicalTrials.gov – link